SLCO1B3 and Hyperbilirubinemia: Interestingly, when the potential implication of OATP1B1/OATP1B3 inhibition in drug-induced hyperbilirubinemia was tested based on in silico predicted inhibitory potencies [82], no strong link between OATP1B inhibition and hyperbilirubinemia was revealed.